Results 171 to 180 of about 2,311,930 (290)

From Long‐Term to Trial‐Ready: 1.5‐Year Follow‐Up in an Established FSHD Cohort Highlights Limitations of Current Outcome Measures

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Identifying endpoints that are sensitive to change is crucial for clinical trial design in facioscapulohumeral muscular dystrophy (FSHD). This study adds follow‐up data to a previously published 5‐year natural history study in the same cohort, aiming to correlate short‐term disease progression to longer term follow‐up ...
Sjan Teeselink   +6 more
wiley   +1 more source

Closed-loop movement-paired transcutaneous auricular vagus nerve stimulation for upper-limb rehabilitation: a feasibility study. [PDF]

open access: yesJ Neuroeng Rehabil
Lhoste C   +8 more
europepmc   +1 more source

Regenerative Peripheral Nerve Interface (RPNI) Surgery for Naturalistic Prosthetic Control

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Loss of limb function remains a significant public health challenge affecting millions of people worldwide, causing high rates of disability, unemployment, and chronic pain. Current neuroprosthetic devices are limited by unintuitive control and poor long‐term embodiment.
Ahneesh J. Mohanty   +7 more
wiley   +1 more source

Electrophysiologic Demyelinating Features Are Common in Vasculitic Neuropathy: A Cohort of Biopsy‐Confirmed Cases

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Electrophysiologic features suggestive of demyelination have been reported in vasculitic neuropathy, complicating the diagnostic process, but their frequency is unknown. We aimed to determine the prevalence of demyelinating features, including fulfillment of European Academy of Neurology/Peripheral Nerve Society (EAN/PNS ...
Alexandra Maury   +7 more
wiley   +1 more source

REHABILITATION IN DISEASES OF THE UPPER LIMB

open access: yesInternational Journal of Clinical Practice, 1952
openaire   +1 more source

Time‐to‐Event Analysis of Clinical Milestones in the ALS Natural History Consortium Dataset

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Study of clinical milestones, particularly intermediate events like loss of ambulation, in large amyotrophic lateral sclerosis (ALS) cohorts is limited. Here, we leverage the ALS Natural History Consortium dataset to evaluate the time‐to‐event for several outcomes and prognostic factors that predict risk. Methods Longitudinal
Kelly Duffy   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy